Trial Profile
The evaluation of duloxetine effect for the parkinsonism and gait freezing
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Dec 2017
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Neurologic gait disorders; Parkinson's disease
- Focus Therapeutic Use
- 22 Dec 2017 Status changed from not yet recruiting to completed.
- 06 Apr 2015 New trial record